Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
RyR2 inhibition with dantrolene is antiarrhythmic, antifi... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
RyR2 inhibition with dantrolene is antiarrhythmic, antifibrotic, and improves cardiac function in chronic ischemic heart disease
0
Authors
Jeffrey Schmeckpeper
7 more
Jeffrey Schmeckpeper
•
Jeong‐Hun Shin
5 more
•
Björn Knollmann
Published
June 28, 2022
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Internal Medicine
Medicine
Cardiology
Pharmacology
Show all topics
DOI
10.1101/2022.06.24.496861
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Internal Medicine
Medicine
Cardiology
Pharmacology
Show all topics
DOI
10.1101/2022.06.24.496861
License
CC-BY-NC-ND
Other Formats
PDF
